APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skin Microbiome Modulator

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Skin Microbiome Modulator Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchSkin Microbiome Modulator Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Microbiome Modulator Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Skin Microbiome Modulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Microbiome Modulator Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Microbiome Modulator Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Skin Microbiome Modulator market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Skin Microbiome Modulator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Skin Microbiome Modulator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Skin Microbiome Modulator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Skin Microbiome Modulator is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Skin Microbiome Modulator include L’Oréal S.A., Unilever, The Estée Lauder Companies, Johnson & Johnson, Revlon, Evelo Biosciences, AOBiome, Azitra and GALLINÉE, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Skin Microbiome Modulator, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Skin Microbiome Modulator, also provides the revenue of main regions and countries. Of the upcoming market potential for Skin Microbiome Modulator, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Skin Microbiome Modulator revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Skin Microbiome Modulator market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Skin Microbiome Modulator revenue, projected growth trends, production technology, application and end-user industry.

Skin Microbiome Modulator Segment by Company

L’Oréal S.A.

Unilever

The Estée Lauder Companies

Johnson & Johnson

Revlon

Evelo Biosciences

AOBiome

Azitra

GALLINÉE

Glowbiotics

Skin Microbiome Modulator Segment by Type

Probiotics

Prebiotics

Drugs

Skin Microbiome Modulator Segment by Application

Skin Care

Hair Care

Others

Skin Microbiome Modulator Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Microbiome Modulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Microbiome Modulator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Microbiome Modulator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Skin Microbiome Modulator in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Skin Microbiome Modulator company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Skin Microbiome Modulator revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Skin Microbiome Modulator Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Probiotics Major Player Table 3. Prebiotics Major Player Table 4. Drugs Major Player Table 5. Global Skin Microbiome Modulator Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Skin Care Major Player Table 7. Hair Care Major Player Table 8. Others Major Player Table 9. Skin Microbiome Modulator Industry Trends Table 10. Skin Microbiome Modulator Industry Drivers Table 11. Skin Microbiome Modulator Industry Opportunities and Challenges Table 12. Skin Microbiome Modulator Industry Restraints Table 13. Global Skin Microbiome Modulator Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Skin Microbiome Modulator Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Skin Microbiome Modulator Market Share by Region (2021-2026) Table 16. Global Skin Microbiome Modulator Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Skin Microbiome Modulator Market Share by Region (2027-2032) Table 18. Global Skin Microbiome Modulator Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Skin Microbiome Modulator Revenue Market Share by Players (2021-2026) Table 20. Global Skin Microbiome Modulator Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Skin Microbiome Modulator Key Players Headquarters & Area Served Table 22. Global Skin Microbiome Modulator Players, Product Type & Application Table 23. Global Skin Microbiome Modulator Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Skin Microbiome Modulator by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Skin Microbiome Modulator Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Skin Microbiome Modulator Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Skin Microbiome Modulator Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Skin Microbiome Modulator Revenue Market Share by Type (2021-2026) Table 30. Global Skin Microbiome Modulator Revenue Market Share by Type (2027-2032) Table 31. Global Skin Microbiome Modulator Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Skin Microbiome Modulator Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Skin Microbiome Modulator Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Skin Microbiome Modulator Revenue Market Share by Application (2021-2026) Table 35. Global Skin Microbiome Modulator Revenue Market Share by Application (2027-2032) Table 36. L’Oréal S.A. Company Information Table 37. L’Oréal S.A. Business Overview Table 38. L’Oréal S.A. Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. L’Oréal S.A. Skin Microbiome Modulator Product Portfolio Table 40. L’Oréal S.A. Recent Development Table 41. Unilever Company Information Table 42. Unilever Business Overview Table 43. Unilever Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Unilever Skin Microbiome Modulator Product Portfolio Table 45. Unilever Recent Development Table 46. The Estée Lauder Companies Company Information Table 47. The Estée Lauder Companies Business Overview Table 48. The Estée Lauder Companies Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. The Estée Lauder Companies Skin Microbiome Modulator Product Portfolio Table 50. The Estée Lauder Companies Recent Development Table 51. Johnson & Johnson Company Information Table 52. Johnson & Johnson Business Overview Table 53. Johnson & Johnson Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Johnson & Johnson Skin Microbiome Modulator Product Portfolio Table 55. Johnson & Johnson Recent Development Table 56. Revlon Company Information Table 57. Revlon Business Overview Table 58. Revlon Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Revlon Skin Microbiome Modulator Product Portfolio Table 60. Revlon Recent Development Table 61. Evelo Biosciences Company Information Table 62. Evelo Biosciences Business Overview Table 63. Evelo Biosciences Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Evelo Biosciences Skin Microbiome Modulator Product Portfolio Table 65. Evelo Biosciences Recent Development Table 66. AOBiome Company Information Table 67. AOBiome Business Overview Table 68. AOBiome Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AOBiome Skin Microbiome Modulator Product Portfolio Table 70. AOBiome Recent Development Table 71. Azitra Company Information Table 72. Azitra Business Overview Table 73. Azitra Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Azitra Skin Microbiome Modulator Product Portfolio Table 75. Azitra Recent Development Table 76. GALLINÉE Company Information Table 77. GALLINÉE Business Overview Table 78. GALLINÉE Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. GALLINÉE Skin Microbiome Modulator Product Portfolio Table 80. GALLINÉE Recent Development Table 81. Glowbiotics Company Information Table 82. Glowbiotics Business Overview Table 83. Glowbiotics Skin Microbiome Modulator Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Glowbiotics Skin Microbiome Modulator Product Portfolio Table 85. Glowbiotics Recent Development Table 86. North America Skin Microbiome Modulator Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Skin Microbiome Modulator Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Skin Microbiome Modulator Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Skin Microbiome Modulator Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Skin Microbiome Modulator Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Skin Microbiome Modulator Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Skin Microbiome Modulator Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Skin Microbiome Modulator Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Skin Microbiome Modulator Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Skin Microbiome Modulator Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Skin Microbiome Modulator Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Skin Microbiome Modulator Revenue by Country (US$ Million) & (2027-2032) Table 100. China Skin Microbiome Modulator Revenue by Type (2021-2026) & (US$ Million) Table 101. China Skin Microbiome Modulator Revenue by Type (2027-2032) & (US$ Million) Table 102. China Skin Microbiome Modulator Revenue by Application (2021-2026) & (US$ Million) Table 103. China Skin Microbiome Modulator Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Skin Microbiome Modulator Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Skin Microbiome Modulator Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Skin Microbiome Modulator Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Skin Microbiome Modulator Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Skin Microbiome Modulator Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Skin Microbiome Modulator Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Skin Microbiome Modulator Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Skin Microbiome Modulator Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Skin Microbiome Modulator Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Skin Microbiome Modulator Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Skin Microbiome Modulator Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Skin Microbiome Modulator Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Skin Microbiome Modulator Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Skin Microbiome Modulator Image Figure 2. Global Skin Microbiome Modulator Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Microbiome Modulator Market Size Share 2021 VS 2025 VS 2032 Figure 4. Probiotics Image Figure 5. Prebiotics Image Figure 6. Drugs Image Figure 7. Global Skin Microbiome Modulator Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Skin Microbiome Modulator Market Size Share 2021 VS 2025 VS 2032 Figure 9. Skin Care Image Figure 10. Hair Care Image Figure 11. Others Image Figure 12. Global Skin Microbiome Modulator Market Size (US$ Million) & (2021-2032) Figure 13. Global Skin Microbiome Modulator Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Skin Microbiome Modulator Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Skin Microbiome Modulator Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Skin Microbiome Modulator Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Skin Microbiome Modulator Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Skin Microbiome Modulator Revenue Market Share by Type (2021-2032) Figure 20. Global Skin Microbiome Modulator Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Skin Microbiome Modulator Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Skin Microbiome Modulator Revenue Market Share by Application (2021-2032) Figure 23. North America Skin Microbiome Modulator Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Skin Microbiome Modulator Revenue Share by Type (2021-2032) Figure 25. North America Skin Microbiome Modulator Revenue Share by Application (2021-2032) Figure 26. North America Skin Microbiome Modulator Revenue Share by Country (2021-2032) Figure 27. United States Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Skin Microbiome Modulator Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Skin Microbiome Modulator Revenue Share by Type (2021-2032) Figure 32. Europe Skin Microbiome Modulator Revenue Share by Application (2021-2032) Figure 33. Europe Skin Microbiome Modulator Revenue Share by Country (2021-2032) Figure 34. Germany Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Skin Microbiome Modulator Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Skin Microbiome Modulator Revenue Share by Type (2021-2032) Figure 44. China Skin Microbiome Modulator Revenue Share by Application (2021-2032) Figure 45. Asia Skin Microbiome Modulator Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Skin Microbiome Modulator Revenue Share by Type (2021-2032) Figure 47. Asia Skin Microbiome Modulator Revenue Share by Application (2021-2032) Figure 48. Asia Skin Microbiome Modulator Revenue Share by Region (2021-2032) Figure 49. Japan Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Skin Microbiome Modulator Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Skin Microbiome Modulator Revenue Share by Type (2021-2032) Figure 57. SAMEA Skin Microbiome Modulator Revenue Share by Application (2021-2032) Figure 58. SAMEA Skin Microbiome Modulator Revenue Share by Country (2021-2032) Figure 59. Brazil Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Skin Microbiome Modulator Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Probiotics
  • Prebiotics
  • Drugs
Applications
  • Skin Care
  • Hair Care
  • Others
Companies covered
  • L’Oréal S.A.
  • Unilever
  • The Estée Lauder Companies
  • Johnson & Johnson
  • Revlon
  • Evelo Biosciences
  • AOBiome
  • Azitra
  • GALLINÉE
  • Glowbiotics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Skin Microbiome Modulator Market by Type
  3. 1.2.1 Global Skin Microbiome Modulator Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Probiotics
  5. 1.2.3 Prebiotics
  6. 1.2.4 Drugs
  7. 1.3 Skin Microbiome Modulator Market by Application
  8. 1.3.1 Global Skin Microbiome Modulator Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Skin Care
  10. 1.3.3 Hair Care
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Skin Microbiome Modulator Market Dynamics
  1. 2.1 Skin Microbiome Modulator Industry Trends
  2. 2.2 Skin Microbiome Modulator Industry Drivers
  3. 2.3 Skin Microbiome Modulator Industry Opportunities and Challenges
  4. 2.4 Skin Microbiome Modulator Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Skin Microbiome Modulator Market Perspective (2021-2032)
  2. 3.2 Global Skin Microbiome Modulator Growth Trends by Region
  3. 3.2.1 Global Skin Microbiome Modulator Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Skin Microbiome Modulator Market Size by Region (2021-2026)
  5. 3.2.3 Global Skin Microbiome Modulator Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Skin Microbiome Modulator Revenue by Players
  2. 4.1.1 Global Skin Microbiome Modulator Revenue by Players (2021-2026)
  3. 4.1.2 Global Skin Microbiome Modulator Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Skin Microbiome Modulator Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Skin Microbiome Modulator Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Skin Microbiome Modulator Key Players Headquarters & Area Served
  7. 4.4 Global Skin Microbiome Modulator Players, Product Type & Application
  8. 4.5 Global Skin Microbiome Modulator Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Skin Microbiome Modulator Market CR5 and HHI
  11. 4.6.3 2025 Skin Microbiome Modulator Tier 1, Tier 2, and Tier 3
5 Skin Microbiome Modulator Market Size by Type
  1. 5.1 Global Skin Microbiome Modulator Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Skin Microbiome Modulator Revenue by Type (2021-2032)
  3. 5.3 Global Skin Microbiome Modulator Revenue Market Share by Type (2021-2032)
6 Skin Microbiome Modulator Market Size by Application
  1. 6.1 Global Skin Microbiome Modulator Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Skin Microbiome Modulator Revenue by Application (2021-2032)
  3. 6.3 Global Skin Microbiome Modulator Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 L’Oréal S.A.
  2. 7.1.1 L’Oréal S.A. Company Information
  3. 7.1.2 L’Oréal S.A. Business Overview
  4. 7.1.3 L’Oréal S.A. Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  5. 7.1.4 L’Oréal S.A. Skin Microbiome Modulator Product Portfolio
  6. 7.1.5 L’Oréal S.A. Recent Developments
  7. 7.2 Unilever
  8. 7.2.1 Unilever Company Information
  9. 7.2.2 Unilever Business Overview
  10. 7.2.3 Unilever Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Unilever Skin Microbiome Modulator Product Portfolio
  12. 7.2.5 Unilever Recent Developments
  13. 7.3 The Estée Lauder Companies
  14. 7.3.1 The Estée Lauder Companies Company Information
  15. 7.3.2 The Estée Lauder Companies Business Overview
  16. 7.3.3 The Estée Lauder Companies Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  17. 7.3.4 The Estée Lauder Companies Skin Microbiome Modulator Product Portfolio
  18. 7.3.5 The Estée Lauder Companies Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Skin Microbiome Modulator Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Revlon
  26. 7.5.1 Revlon Company Information
  27. 7.5.2 Revlon Business Overview
  28. 7.5.3 Revlon Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Revlon Skin Microbiome Modulator Product Portfolio
  30. 7.5.5 Revlon Recent Developments
  31. 7.6 Evelo Biosciences
  32. 7.6.1 Evelo Biosciences Company Information
  33. 7.6.2 Evelo Biosciences Business Overview
  34. 7.6.3 Evelo Biosciences Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Evelo Biosciences Skin Microbiome Modulator Product Portfolio
  36. 7.6.5 Evelo Biosciences Recent Developments
  37. 7.7 AOBiome
  38. 7.7.1 AOBiome Company Information
  39. 7.7.2 AOBiome Business Overview
  40. 7.7.3 AOBiome Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AOBiome Skin Microbiome Modulator Product Portfolio
  42. 7.7.5 AOBiome Recent Developments
  43. 7.8 Azitra
  44. 7.8.1 Azitra Company Information
  45. 7.8.2 Azitra Business Overview
  46. 7.8.3 Azitra Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Azitra Skin Microbiome Modulator Product Portfolio
  48. 7.8.5 Azitra Recent Developments
  49. 7.9 GALLINÉE
  50. 7.9.1 GALLINÉE Company Information
  51. 7.9.2 GALLINÉE Business Overview
  52. 7.9.3 GALLINÉE Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GALLINÉE Skin Microbiome Modulator Product Portfolio
  54. 7.9.5 GALLINÉE Recent Developments
  55. 7.10 Glowbiotics
  56. 7.10.1 Glowbiotics Company Information
  57. 7.10.2 Glowbiotics Business Overview
  58. 7.10.3 Glowbiotics Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Glowbiotics Skin Microbiome Modulator Product Portfolio
  60. 7.10.5 Glowbiotics Recent Developments
8 North America
  1. 8.1 North America Skin Microbiome Modulator Revenue (2021-2032)
  2. 8.2 North America Skin Microbiome Modulator Revenue by Type (2021-2032)
  3. 8.2.1 North America Skin Microbiome Modulator Revenue by Type (2021-2026)
  4. 8.2.2 North America Skin Microbiome Modulator Revenue by Type (2027-2032)
  5. 8.3 North America Skin Microbiome Modulator Revenue Share by Type (2021-2032)
  6. 8.4 North America Skin Microbiome Modulator Revenue by Application (2021-2032)
  7. 8.4.1 North America Skin Microbiome Modulator Revenue by Application (2021-2026)
  8. 8.4.2 North America Skin Microbiome Modulator Revenue by Application (2027-2032)
  9. 8.5 North America Skin Microbiome Modulator Revenue Share by Application (2021-2032)
  10. 8.6 North America Skin Microbiome Modulator Revenue by Country
  11. 8.6.1 North America Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Skin Microbiome Modulator Revenue by Country (2021-2026)
  13. 8.6.3 North America Skin Microbiome Modulator Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Skin Microbiome Modulator Revenue (2021-2032)
  2. 9.2 Europe Skin Microbiome Modulator Revenue by Type (2021-2032)
  3. 9.2.1 Europe Skin Microbiome Modulator Revenue by Type (2021-2026)
  4. 9.2.2 Europe Skin Microbiome Modulator Revenue by Type (2027-2032)
  5. 9.3 Europe Skin Microbiome Modulator Revenue Share by Type (2021-2032)
  6. 9.4 Europe Skin Microbiome Modulator Revenue by Application (2021-2032)
  7. 9.4.1 Europe Skin Microbiome Modulator Revenue by Application (2021-2026)
  8. 9.4.2 Europe Skin Microbiome Modulator Revenue by Application (2027-2032)
  9. 9.5 Europe Skin Microbiome Modulator Revenue Share by Application (2021-2032)
  10. 9.6 Europe Skin Microbiome Modulator Revenue by Country
  11. 9.6.1 Europe Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Skin Microbiome Modulator Revenue by Country (2021-2026)
  13. 9.6.3 Europe Skin Microbiome Modulator Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Skin Microbiome Modulator Revenue (2021-2032)
  2. 10.2 China Skin Microbiome Modulator Revenue by Type (2021-2032)
  3. 10.2.1 China Skin Microbiome Modulator Revenue by Type (2021-2026)
  4. 10.2.2 China Skin Microbiome Modulator Revenue by Type (2027-2032)
  5. 10.3 China Skin Microbiome Modulator Revenue Share by Type (2021-2032)
  6. 10.4 China Skin Microbiome Modulator Revenue by Application (2021-2032)
  7. 10.4.1 China Skin Microbiome Modulator Revenue by Application (2021-2026)
  8. 10.4.2 China Skin Microbiome Modulator Revenue by Application (2027-2032)
  9. 10.5 China Skin Microbiome Modulator Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Skin Microbiome Modulator Revenue (2021-2032)
  2. 11.2 Asia Skin Microbiome Modulator Revenue by Type (2021-2032)
  3. 11.2.1 Asia Skin Microbiome Modulator Revenue by Type (2021-2026)
  4. 11.2.2 Asia Skin Microbiome Modulator Revenue by Type (2027-2032)
  5. 11.3 Asia Skin Microbiome Modulator Revenue Share by Type (2021-2032)
  6. 11.4 Asia Skin Microbiome Modulator Revenue by Application (2021-2032)
  7. 11.4.1 Asia Skin Microbiome Modulator Revenue by Application (2021-2026)
  8. 11.4.2 Asia Skin Microbiome Modulator Revenue by Application (2027-2032)
  9. 11.5 Asia Skin Microbiome Modulator Revenue Share by Application (2021-2032)
  10. 11.6 Asia Skin Microbiome Modulator Revenue by Country
  11. 11.6.1 Asia Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Skin Microbiome Modulator Revenue by Country (2021-2026)
  13. 11.6.3 Asia Skin Microbiome Modulator Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Skin Microbiome Modulator Revenue (2021-2032)
  2. 12.2 SAMEA Skin Microbiome Modulator Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Skin Microbiome Modulator Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Skin Microbiome Modulator Revenue by Type (2027-2032)
  5. 12.3 SAMEA Skin Microbiome Modulator Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Skin Microbiome Modulator Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Skin Microbiome Modulator Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Skin Microbiome Modulator Revenue by Application (2027-2032)
  9. 12.5 SAMEA Skin Microbiome Modulator Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Skin Microbiome Modulator Revenue by Country
  11. 12.6.1 SAMEA Skin Microbiome Modulator Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Skin Microbiome Modulator Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Skin Microbiome Modulator Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst